Drug Profile
DS 8190
Latest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company
- Class Small molecules
- Mechanism of Action Acyltransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atherosclerosis
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for preclinical development in Atherosclerosis in Japan
- 11 Nov 2017 Preclinical trials in Atherosclerosis in Japan (unspecified route)
- 11 Nov 2017 Pharmacokinetic data from preclinical study in Atherosclerosis presented at the 90th Annual Scientific Sessions of the American Heart Association (AHA-2017)